Belosalik - instructions for use, doses, side effects, contraindications

Betamethasone has anti-inflammatory, antiallergic, antiproliferative and antipruritic actions. When applied to the skin surface betamethasone has a rapid and strong effect in the inflammatory focus, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).

Salicylic acid due to keratolytic action clears lesions from scales, promotes the penetration of betamethasone into the skin, supports the acidic environment of the skin, preventing the development of bacterial and fungal infection.

Indications:

BELOSALIK® is used for the therapy of subacute and chronic dermatoses, sensitive to external corticosteroid therapy, accompanied by hyperkeratosis and desquamation.

Psoriasis, eczema (dysgidrotic, seborrheic, tylotic), neurodermatitis, red flat lichen, chronic discoid lupus erythematosus, ichthyosis and ichthyosis skin lesions, etc.

Contraindications:

Hypersensitivity to betamethasone, salicylic acid or to any of the auxiliary components of the drug.

Tuberculosis of the skin, cutaneous manifestations of syphilis, chickenpox, viral skin infections, skin post-vaccination reactions, open wounds, trophic ulcers, rosacea, vulgar acne, children under 6 months.

Carefully:

Hepatic insufficiency, children's age, long-term therapy, especially with the use of occlusive dressings.

Pregnancy and lactation:

The local use of BELOSALIK® in pregnant women is allowed in cases where the intended benefit to the mother exceeds the risk to the fetus. In such cases, the use of the drug should be short and limited to small areas of skin.

In the period of breastfeeding, the use of the drug BELOSALIK^® possibly on strict indications, but the drug should not be applied to the skin of the breast before feeding.

Dosing and Administration:

Outwardly.

The preparation BELOSALIK® in the form of ointment for external use is intended for use on smooth skin.

BELOSALIK^® ointment is applied twice a day. A small amount of ointment is evenly distributed over the surface of the skin, gently rubbing. In light cases, a single use is sufficient.

The course of treatment, as a rule, is 3-4 weeks. If a longer course of therapy is required, the drug should be used less frequently, for example, every other day.

In the treatment of chronic diseases, treatment should continue for some time afterthe disappearance of all symptoms under the supervision of a doctor to avoid relapse of the disease. During the year, repeated therapy is possible.

Side effects:

Side effects, as a rule, are mildly expressed.

A hypersensitivity reaction may develop (itching, burning or redness).

Rarely, as with the application of other glucocorticosteroids, acne-like changes, hypopigmentation, striae, skin atrophy, hypertrichosis, telangiectasia, secondary skin infections.

With prolonged continuous use and in large areas of the skin, topical application of betamethasone can cause systemic side effects associated with suppression of adrenal cortex function.

In case of a hypersensitivity reaction or side effects, therapy should be discontinued and consult a doctor.

Overdose:

With prolonged continuous use of combination betamethasone and salicylic acid, especially in children, over extensive skin surfaces, when applied to the skin with impaired integrity or when used under an occlusive dressing, increased absorption of active components and manifestations of systemic affects (secondary adrenal insufficiency, hypercortisy, syndrome Cushing's).In this case, it is recommended to cancel the drug and symptomatic therapy.

Interaction:

There were no clinically significant interactions with other drugs.

Simultaneous use of cosmetic and dermatological agents for the therapy of acne, agents containing ethanol or medical soap with a pronounced drying effect, etc., can in certain cases cause skin irritation.

Special instructions:

BELOSALIK® ointment is intended for external use only on the skin and / or the scalp.

Avoid contact with eyes and mucous membranes. It is not recommended to use the ointment on the face skin for a long time due to the possible development of dermatitis by the type of rosacea, perioral dermatitis, atrophy of the skin and acne. Avoid application of the drug in the anogenital area.

It is not recommended to use the drug under an occlusive dressing, except when it is necessary.

When developing fungal or bacterial microflora on the skin, an additional use of an antibacterial or antifungal agent is necessary.

Use in Pediatrics

The use of BELOSALIK® in children should be short-lived with strict precautions, since children are at risk of systemic absorption in proportion to the greater number of active components due to the predominance of the skin area over the body weight and the insufficient maturity of the epidermis.

Do not use the drug in children under the bandages and especially under plasticized diapers, which can increase the risk of developing unwanted phenomena.

Effect on the ability to drive transp. cf. and fur:

Data on the adverse effects of BELOSALIK® on the ability to drive vehicles and mechanisms are not available.

Form release / dosage:

Ointment for external use.

Packaging:

For 20 g, 30 g and 40 g in an aluminum tube.

The tube opening is protected by a membrane. The tube is closed with a polyethylene lid with a thread and a punch. Each tube together with the instruction for use is placed in a cardboard box.

Storage conditions:

At a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

4 years.

Do not use after the expiry date stated on the package.

Terms of leave from pharmacies:Without recipe

Registration number:П N014695 / 01

Date of registration:31.03.2008 / 17.05.2016

Expiration Date:Unlimited

The owner of the registration certificate:Beluga, medicines and cosmetics.Beluga, medicines and cosmetics. Croatia

Manufacturer: & nbsp

BELUPO, Pharmaceuticals & Cosmetics, d.d. Croatia

Representation: & nbspBeluga, medicines and cosmetics. Beluga, medicines and cosmetics. Croatia

Information update date: & nbsp21.01.2017

Illustrated instructions

Instructions

Belosalik® (Belosalic® )